Sign In
Get Clay Free →

Suggestions

    Eric Lefebvre

    Chief Medical Officer at Pliant Therapeutics

    Professional Background

    Eric Lefebvre is a distinguished Chief Medical Officer with a wealth of experience in the dynamic fields of biotechnology and pharmaceuticals. His career encompasses a diverse range of roles, reflecting his adeptness in clinical development across various stages – from early to late-stage progression in drug development. Over the years, Eric has built an impressive portfolio of expertise in addressing complex health challenges, with a particular focus on fibrotic diseases such as Idiopathic Pulmonary Fibrosis (IPF), Primary Sclerosing Cholangitis (PSC), and Nonalcoholic Steatohepatitis (NASH), as well as virology, specifically HIV/AIDS and Hepatitis C. His proficiency in clinical pharmacology and translational medicine further illustrates his breadth of knowledge in advancing healthcare solutions that directly impact patient lives.

    Eric’s career trajectory has seen him take on pivotal roles within some of the most respected organizations in the healthcare industry. As a former Chief Medical Officer at several prominent firms, including Pliant Therapeutics and Tobira Therapeutics, he has played a critical role in guiding clinical strategy and medical affairs. His tenure as Vice President at Allergan and as Global Medical Affairs Leader at Janssen Inc. underscores his capability to lead initiatives that harmonize scientific innovation with therapeutic application. Furthermore, his leadership as Global Clinical Development Leader at Janssen Inc. attests to his prowess in driving clinical programs that bring new therapies to market.

    Education and Achievements

    Eric Lefebvre’s academic journey laid a robust foundation for his successful career in medicine and healthcare. He pursued his Bachelor of Science (B.S.) at College Edouard Montpetit and further honed his medical expertise by earning a Doctor of Medicine (M.D.) degree from the esteemed University of Montreal. This educational background has equipped him with the scientific knowledge and clinical acumen necessary to excel in the highly competitive biotech and pharma landscapes.

    Throughout his professional journey, Eric has garnered numerous achievements that reflect his dedication to advancing medicine. His involvements on the Board of Directors at CymaBay Therapeutics highlight his influence in shaping strategic decision-making and governance in biotech innovation. At every organization he served, Eric has not only contributed in a clinical capacity but has also actively shape research agendas that prioritize patient outcomes and therapeutic integrity.

    Notable Leadership Roles

    Eric has demonstrated exceptional leadership in various capacities, including:

    • Chief Medical Officer, Pliant Therapeutics: In this role, he was integral to steering research programs for innovative therapeutic interventions.
    • Vice President, Allergan: Eric contributed to the strategic direction and execution of comprehensive global medical strategies.
    • Chief Medical Officer, Tobira Therapeutics: His leadership was pivotal in advancing clinical trials designed to address critical therapeutic gaps.
    • Global Medical Affairs Leader, Janssen Inc.: Here, Eric facilitated the alignment between clinical research and medical strategies at a global scale.
    • Medical Director, HIV and Vaccines, GSK: He was instrumental in leading initiatives focused on infectious disease prevention and treatment, contributing to significant advancements in vaccine technology.
    • Co-Director at Clinique Médicale l'Actuel: Eric's hands-on experience as a healthcare provider enriched his understanding of patient needs, which informs his strategic vision in medical affairs.

    Commitment to Healthcare

    A passionate advocate for improving patient care, Eric Lefebvre has been instrumental in fostering collaboration between medical science and clinical practice. His leadership has ensured that clinical development pathways align with regulatory standards while remaining firmly grounded in improving patient outcomes. As a firm believer in innovation, Eric continues to contribute to research that pushes the boundaries of current medical knowledge, with the aim of delivering lasting solutions for patients in need.

    Achievements

    Eric Lefebvre has built a legacy of impactful contributions to the field of medical sciences, driven by a mission to innovate in the service of health. His numerous leadership roles in high-profile organizations exemplify his commitment to advancing clinical understanding, enhancing therapeutic regimens, and driving strategic initiatives that prioritize patient health and safety.

    Related Questions

    How did Eric Lefebvre develop his expertise in fibrotic diseases such as IPF and NASH?
    What were some key strategies Eric Lefebvre implemented during his time at Allergan as Vice President?
    In what ways has Eric Lefebvre contributed to the advancement of HIV treatment during his career?
    How has Eric Lefebvre’s education at the University of Montreal shaped his professional journey in the healthcare industry?
    What influences did Eric Lefebvre bring to his role as Chief Medical Officer at Pliant Therapeutics?
    E
    Add to my network

    Location

    South San Francisco, California, United States